CRISPR Therapeutics (CRSP) PT Raised to $56 at Bernstein SocGen Group
Tweet
Share
E-mailGet Alerts CRSP Hot Sheet
Price: $55.62 +1.98%
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 11 | New: 25
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 11 | New: 25
Join SI Premium – FREE
Bernstein SocGen Group analyst William Pickering raised the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $56.00 (from $50.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- MSC Industrial (MSM) PT Raised to $145 at KeyBanc
- LTIMindtree Ltd (LTIM:IN) PT Lowered to INR4,080 at UBS
- United Rentals (URI) PT Raised to $1,300 at UBS on Increased Conviction in Non-Res Rebound
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
